FDA approves 1st agitation drug for Alzheimer's patients

By Becker's Hospital Review - Healthcare News in Becker's Hospital Review, Channels, Featured, ROOT
May 11, 2023

The FDA approved the first drug that treats agitation associated with Alzheimer’s disease.

Read the full post on Becker's Hospital Review - Healthcare News

Becker's Hospital Review - Healthcare News